Kiadis Pharma starts a P I/II clinical trial for thalassemia treatment
Kiadis Pharma N.V., a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders
Read more
Kiadis Pharma N.V